Rocket Pharmaceuticals, Inc. (RCKT)
3.665
-0.12
(-3.04%)
USD |
NASDAQ |
Aug 26, 16:00
3.665
0.00 (0.00%)
After-Hours: 20:00
Rocket Pharmaceuticals Total Assets (Quarterly) : 423.10M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 423.10M |
| March 31, 2026 | 285.41M |
| December 31, 2025 | 330.45M |
| September 30, 2025 | 368.03M |
| June 30, 2025 | 420.98M |
| March 31, 2025 | 471.07M |
| December 31, 2024 | 527.70M |
| September 30, 2024 | 393.69M |
| June 30, 2024 | 446.41M |
| March 31, 2024 | 499.44M |
| December 31, 2023 | 566.34M |
| September 30, 2023 | 598.76M |
| June 30, 2023 | 461.78M |
| March 31, 2023 | 514.76M |
| December 31, 2022 | 551.81M |
| September 30, 2022 | 417.26M |
| June 30, 2022 | 431.85M |
| March 31, 2022 | 460.15M |
| December 31, 2021 | 497.02M |
| September 30, 2021 | 530.24M |
| June 30, 2021 | 535.15M |
| March 31, 2021 | 576.48M |
| December 31, 2020 | 590.82M |
| September 30, 2020 | 335.50M |
| June 30, 2020 | 353.06M |
| Date | Value |
|---|---|
| March 31, 2020 | 372.75M |
| December 31, 2019 | 372.12M |
| September 30, 2019 | 299.91M |
| June 30, 2019 | 308.72M |
| March 31, 2019 | 242.14M |
| December 31, 2018 | 251.31M |
| September 30, 2018 | 194.98M |
| June 30, 2018 | 207.57M |
| March 31, 2018 | 217.16M |
| December 31, 2017 | 20.15M |
| September 30, 2017 | 104.66M |
| June 30, 2017 | 111.06M |
| March 31, 2017 | 117.92M |
| December 31, 2016 | 129.65M |
| September 30, 2016 | 140.14M |
| June 30, 2016 | 99.85M |
| March 31, 2016 | 104.21M |
| December 31, 2015 | 113.32M |
| September 30, 2015 | 120.12M |
| June 30, 2015 | 51.69M |
| March 31, 2015 | 55.53M |
| December 31, 2014 | 5.52M |
| September 30, 2014 | 6.498M |
| June 30, 2014 | |
| March 31, 2014 |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 2.112B |
| Oncolytics Biotech, Inc. | 7.671M |
| Sangamo Therapeutics, Inc. | 59.96M |
| Sarepta Therapeutics, Inc. | 3.189B |
| Anixa Biosciences, Inc. | 14.86M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 54.27M |
| Shareholders Equity (Quarterly) | 368.83M |
| Debt to Equity Ratio | 0.0672 |
| Current Ratio | 9.245 |
| Net Debt Paydown Yield | 0.03% |